Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Surgical-site infections in infants undergoing surgery for congenital heart disease during their first year of life.

JTCVS open·2026
Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026
Same author

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

JACC. Advances·2026
Same author

Scrolling for science: Assessing the quality and accuracy of Crohn's disease-related content on Instagram reels.

PloS one·2026
Same author

Risk of Thromboembolic Events in Patients With Polycythemia Vera: A Real-World Observational Study.

Clinical lymphoma, myeloma & leukemia·2026

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.3K

NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.

Jason Gotlib1, Aaron T Gerds2, Peter Abdelmessieh3

  • 11Stanford Cancer Institute.

Journal of the National Comprehensive Cancer Network : JNCCN
|June 11, 2024
PubMed
Summary

Mastocytosis encompasses various disorders affecting mast cells, leading to diverse symptoms. Recent NCCN Guidelines offer updated recommendations for diagnosing and managing systemic mastocytosis comprehensively.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.4K

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.4K

Area of Science:

  • Hematology
  • Oncology

Background:

  • Mastocytosis is a rare disease group characterized by mast cell proliferation.
  • Symptoms arise from mediator release and tissue infiltration, impacting multiple organ systems.
  • Management requires specialized care and multidisciplinary collaboration.

Purpose of the Study:

  • To summarize recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for Systemic Mastocytosis.
  • To highlight evidence- and consensus-based recommendations for diagnosis and care.
  • To inform clinicians about evolving therapeutic strategies.

Main Methods:

  • Review of NCCN Guidelines for Systemic Mastocytosis.
  • Analysis of recent updates based on expert consensus and emerging data.
  • Focus on changes related to diagnosis, treatment, and supportive care.

Main Results:

  • The NCCN Guidelines provide a framework for comprehensive patient management.
  • Updates address new therapies and refine existing recommendations.
  • Emphasis on multidisciplinary care involving specialists like allergists and anesthesiologists.

Conclusions:

  • Regular guideline updates ensure evidence-based care for systemic mastocytosis.
  • Multidisciplinary collaboration is crucial for optimal patient outcomes.
  • These insights reflect the latest advancements in mastocytosis management.